Heinz H Schmeiser Selected Research

1-phenylazo-2-naphthol (Sudan I)

1/2014	Enzymes oxidizing the azo dye 1-phenylazo-2-naphthol (Sudan I) and their contribution to its genotoxicity and carcinogenicity.
2/2013	Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
9/2009	Oxidation of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxy-naphthalene (Sudan I) by cytochromes P450 and peroxidases: a comparative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heinz H Schmeiser Research Topics

Disease

51	Neoplasms (Cancer) 09/2021 - 04/2002
26	Balkan Nephropathy (Balkan Endemic Nephropathy) 09/2021 - 10/2002
7	Carcinogenesis 01/2019 - 07/2002
6	Body Weight (Weight, Body) 01/2019 - 01/2003
5	Lung Neoplasms (Lung Cancer) 01/2019 - 03/2008
5	Carcinoma (Carcinomatosis) 02/2016 - 02/2003
4	Fibrosis (Cirrhosis) 03/2010 - 06/2008
3	Chronic Kidney Failure (Chronic Renal Failure) 03/2009 - 06/2008
2	Neuroblastoma 01/2019 - 01/2018
2	Renal Insufficiency (Renal Failure) 03/2013 - 02/2003
1	Glioma (Gliomas) 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 02/2015
1	Carcinoma in Situ 02/2015
1	Poisoning 10/2012
1	Inflammation (Inflammations) 05/2010
1	Atrophy 03/2010
1	Polyps 01/2010
1	Breast Neoplasms (Breast Cancer) 04/2004
1	Hepatocellular Carcinoma (Hepatoma) 01/2004

Drug/Important Bio-Agent (IBA)

44	aristolochic acid I (aristolochic acid)IBA 09/2021 - 04/2002
16	CarcinogensIBA 01/2018 - 04/2002
15	DNA AdductsIBA 01/2019 - 07/2002
8	EnzymesIBA 10/2017 - 03/2006
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2004
5	Pharmaceutical PreparationsIBA 01/2018 - 07/2002
5	Codon (Codons)IBA 03/2016 - 03/2004
4	ellipticineIBA 01/2019 - 07/2006
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2007
4	AlkaloidsIBA 10/2017 - 10/2008
4	MutagensIBA 10/2009 - 11/2006
3	Plant ExtractsIBA 09/2021 - 01/2014
3	1-phenylazo-2-naphthol (Sudan I)IBA 01/2014 - 09/2009
2	CytochromesIBA 01/2019 - 01/2005
2	Environmental Pollutants (Pollutants, Environmental)IBA 06/2012 - 03/2009
2	2-anisidine (o-anisidine)IBA 06/2012 - 03/2009
2	Vehicle Emissions (Emissions, Vehicle)IBA 10/2009 - 01/2009
2	3-nitrobenzanthroneIBA 10/2009 - 01/2004
1	Aristolochic AcidsIBA 09/2021
1	ApoferritinsIBA 01/2019
1	N'-nitrosonornicotine (nitrosonornicotine)IBA 01/2019
1	5-hydroxymethylcytosineIBA 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	NitrosaminesIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 03/2015
1	IonsIBA 01/2015
1	ochratoxin AIBA 01/2015
1	Heavy MetalsIBA 01/2015
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2014
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2014
1	Environmental CarcinogensIBA 02/2013
1	Azo CompoundsIBA 02/2013
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Leukotriene A4IBA 05/2010
1	LipidsIBA 05/2010
1	RNA (Ribonucleic Acid)IBA 01/2010
1	NucleotidesIBA 01/2010
1	N-hydroxy-3-aminobenzanthroneIBA 10/2009
1	AminesIBA 03/2009
1	2-nitroanisoleIBA 03/2009
1	Particulate MatterIBA 03/2008
1	Biological ProductsIBA 01/2007
1	Oxidoreductases (Dehydrogenase)IBA 03/2006
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2006
1	SmokeIBA 04/2005
1	Benzo(a)pyreneIBA 04/2005
1	NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA 01/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2005
1	Adenosine (Adenocard)FDA LinkGeneric 04/2004
1	N-acetyl-N-hydroxy-3-aminobenzanthroneIBA 01/2003

Therapy/Procedure

2	Lasers (Laser) 01/2019 - 01/2019
1	Nephroureterectomy 02/2016
1	Therapeutics 02/2015
1	Kidney Transplantation 02/2015
1	Intravesical Administration 02/2015
1	Aftercare (After-Treatment) 01/2011